Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jimmy Ruiz

Showing results (31-40 of 99) with videos related to

Pageof 10
Sort By:
Neuro-Oncology|August 31, 2016
Predictors of neurologic and nonneurologic death in patients with brain metastasis initially treated with upfront stereotactic radiosurgery without whole-brain radiation therapyEmory R McTyre, Adam G Johnson, Jimmy Ruiz, et al.
Cancers|April 1, 2020
Dysregulated Pyrimidine Biosynthesis Contributes to 5-FU Resistance in SCLC Patient-Derived Organoids but Response to a Novel Polymeric Fluoropyrimidine, CF10William H Gmeiner, Lance D Miller, Jeff W Chou, et al.
Clinical Lung Cancer|January 10, 2020
Patient-Reported Outcomes From Patients Receiving Immunotherapy or Chemoimmunotherapy for Metastatic Non-Small-Cell Lung Cancer in Clinical PracticeLaurie E Steffen McLouth, Thomas W Lycan, Beverly J Levine, et al.
Journal of Neuro-Oncology|October 28, 2018
Surgical resection and postoperative radiosurgery versus staged radiosurgery for large brain metastasesAmmoren E Dohm, Ryan Hughes, William Wheless, et al.
Journal of Neuro-Oncology|August 27, 2011
A phase II trial of thalidomide and procarbazine in adult patients with recurrent or progressive malignant gliomasJimmy Ruiz, Doug Case, Gina Enevold, et al.
Neurosurgery|July 9, 2018
Clinical Outcomes of Upfront Stereotactic Radiosurgery Alone for Patients With 5 to 15 Brain MetastasesRyan T Hughes, Emory R McTyre, Michael LeCompte, et al.
Lung Cancer (Amsterdam, Netherlands)|April 9, 2025
Randomized phase 2 trial of pembrolizumab alone or in combination with low dose chemotherapy for patients with non-small cell lung cancer and poor performance statusSafoa Addo, Thomas Lycan, David R Soto-Pantoja, et al.
Communications Biology|July 21, 2023
Single-cell sequencing reveals the landscape of the human brain metastatic microenvironmentQianqian Song, Jimmy Ruiz, Fei Xing, et al.
Journal of Radiosurgery and SBRT|January 4, 2018
Local control of brain metastases after stereotactic radiosurgery: the impact of whole brain radiotherapy and treatment paradigmRyan T Hughes, Paul J Black, Brandi R Page, et al.
Clinical Neurology and Neurosurgery|February 29, 2024
Brain metastases from renal cell carcinoma: Effects of novel systemic agents on brain metastasis outcomesHadley W Ressler, Christina K Cramer, Scott Isom, et al.
Pageof 10

Showing results (31-40 of 99) with videos related to

Sort By:
Pageof 10
Neuro-Oncology|August 31, 2016
Predictors of neurologic and nonneurologic death in patients with brain metastasis initially treated with upfront stereotactic radiosurgery without whole-brain radiation therapyEmory R McTyre, Adam G Johnson, Jimmy Ruiz, et al.
Cancers|April 1, 2020
Dysregulated Pyrimidine Biosynthesis Contributes to 5-FU Resistance in SCLC Patient-Derived Organoids but Response to a Novel Polymeric Fluoropyrimidine, CF10William H Gmeiner, Lance D Miller, Jeff W Chou, et al.
Clinical Lung Cancer|January 10, 2020
Patient-Reported Outcomes From Patients Receiving Immunotherapy or Chemoimmunotherapy for Metastatic Non-Small-Cell Lung Cancer in Clinical PracticeLaurie E Steffen McLouth, Thomas W Lycan, Beverly J Levine, et al.
Journal of Neuro-Oncology|October 28, 2018
Surgical resection and postoperative radiosurgery versus staged radiosurgery for large brain metastasesAmmoren E Dohm, Ryan Hughes, William Wheless, et al.
Journal of Neuro-Oncology|August 27, 2011
A phase II trial of thalidomide and procarbazine in adult patients with recurrent or progressive malignant gliomasJimmy Ruiz, Doug Case, Gina Enevold, et al.
Neurosurgery|July 9, 2018
Clinical Outcomes of Upfront Stereotactic Radiosurgery Alone for Patients With 5 to 15 Brain MetastasesRyan T Hughes, Emory R McTyre, Michael LeCompte, et al.
Lung Cancer (Amsterdam, Netherlands)|April 9, 2025
Randomized phase 2 trial of pembrolizumab alone or in combination with low dose chemotherapy for patients with non-small cell lung cancer and poor performance statusSafoa Addo, Thomas Lycan, David R Soto-Pantoja, et al.
Communications Biology|July 21, 2023
Single-cell sequencing reveals the landscape of the human brain metastatic microenvironmentQianqian Song, Jimmy Ruiz, Fei Xing, et al.
Journal of Radiosurgery and SBRT|January 4, 2018
Local control of brain metastases after stereotactic radiosurgery: the impact of whole brain radiotherapy and treatment paradigmRyan T Hughes, Paul J Black, Brandi R Page, et al.
Clinical Neurology and Neurosurgery|February 29, 2024
Brain metastases from renal cell carcinoma: Effects of novel systemic agents on brain metastasis outcomesHadley W Ressler, Christina K Cramer, Scott Isom, et al.
Pageof 10